Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Fresenius Medical Care AG: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna 
. The transaction toke place on 4th December 2023. . The aggregated volume was 198.714,19 EUR, based on an average price of 38,57 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 4th December 2023. . The aggregated volume was 198.714,19 EUR, based on an average price of 38,57 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place CBOE Europe. . The aggregated volume was 10.933,84 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Turqoise Europe. . The aggregated volume was 11.199,36 EUR, based on an average price of 36,84 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 9.608,67 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Aquis Exchange Europe. . The aggregated volume was 4.343,80 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place CBOE Europe. . The aggregated volume was 10.933,84 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Turqoise Europe. . The aggregated volume was 11.199,36 EUR, based on an average price of 36,84 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 9.608,67 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Aquis Exchange Europe. . The aggregated volume was 4.343,80 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 15th June 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th June 2022,
The Insider Transaction was made by Maddux, Franklin W. . The transaction toke place on 14th June 2022. The order was executed at the trading place XETRA. . The aggregated volume was 762.851,09 EUR, based on an average price of 50,86 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 27th May 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th May 2022,
The Insider Transaction was made by Powell, Rice . The transaction toke place on 24th May 2022. The order was executed at the trading place XETRA. . The aggregated volume was 2.792.923,58 EUR, based on an average price of 56,00 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 27th May 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th May 2022,
The Insider Transaction was made by Powell, Rice . The transaction toke place on 24th May 2022. . The aggregated volume was 1.391.093,80 EUR, based on an average price of 56,02 EUR. The nature of the Investment was not specified.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 31 | 21st November 2023 | EQS Group AG | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 11 | 14th May 2024 | Kintbury Capital LLP | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.